Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ajax 3 appears to refer not to a standalone operating biotech or pharma company, but to Ajax Health's third venture vehicle, commonly called Ajax 3 or Ajax Health III. Ajax Health is a private healthcare investment and company-building firm focused primarily on medtech, healthcare services, and healthcare IT rather than therapeutic drug development. The firm takes an active operating role in identifying, funding, and scaling healthcare businesses, often partnering with established industry leaders to accelerate product portfolio creation and commercialization. Its model is best described as a medtech innovation platform and venture investor rather than a traditional drug developer with a disclosed therapeutic pipeline. Because the requested name "Ajax 3" maps most directly to a fund/vehicle under Ajax Health, the closest canonical company-level match is Ajax Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ajax 3.